IP Library Granted Patent US 8,043,270
Granted Patent B2
US 8,043,270 · App. 11/718,541 · Granted Oct 25, 2011

Pharmaceutical analysis apparatus and method

Assignee: GlaxoSmith Kline LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,043,270
App. No.
11/718,541
Granted
Oct 25, 2011
Kind
B2
Abstract

An apparatus and method are provided for analyzing the release of active agent(s) from pharmaceutical and pharmaceutical-like products. The apparatus and method provide for more accurate simulation of the conditions in the GI tract including forces that are applied to the dosage form.

Claims (15)

1. A dissolution device to analyze the release of an active agent from a dosage form in a GI tract, the device comprising:

a vessel having an open end, said vessel containing a medium; and

a force application system having a chamber and a force imparting mechanism,

said chamber supporting the dosage form and being in fluid communication with said medium, wherein said force imparting mechanism applies compression to the dosage form to simulate conditions in the GI tract.

2. The device of claim 1 , wherein said force application system is connected to said open end thereby being positioned in said medium.

3. The device of claim 1 , wherein said chamber is a cylinder, said force imparting mechanism comprises a piston, and said piston is operably connected to a power source.

4. The device of claim 3 , further comprising a controller operably connected to said piston to control at least one of a frequency, a duration or an amount of said compression that is applied to the dosage form.

5. The device of claim 3 , further comprising an impeller that circulates said medium.

6. The device of claim 5 , further comprising a sampler that obtains a sample of said medium for analysis.

7. The device of claim 3 , wherein said cylinder has one or more slots that allow for flow of said medium into and through said cylinder.

8. The device of claim 7 , wherein said cylinder has a mesh screen along a bottom of said cylinder.

9. The device of claim 3 , wherein said cylinder has a first mesh screen along a bottom of said cylinder and a second mesh screen above said first mesh screen that sandwiches the dosage form in place.

10. The device of claim 1 , wherein said force application system has padding positioned between the dosage form and said force imparting mechanism.

11. The device of claim 10 , wherein said padding is silicon.

12. The device of claim 1 , wherein said force application system is made at least in part from electropolished stainless steel.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 17, 2015
From: GLAXOSMITHKLINE, LLC
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
Reel/Frame 034970/0762 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 17, 2015
From: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO. 2) LIMITED
To: DISTEK INC.
Reel/Frame 034971/0001 →
CHANGE OF NAME Recorded Sep 21, 2011
From: SMITHKLINE BEECHAM CORPORATION
To: GLAXOSMITHKLINE LLC
Reel/Frame 026945/0012 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 3, 2007
From: BURKE, MATTHEW D; MAHESHWARI, CHINMAY R; ZIMMERMAN, BRIAN O
To: SMITHKLINE BEECHAM CORPORATION
Reel/Frame 019243/0822 →
Continuity (2)
Provisional Application 60625620 · Nov 5, 2004
Related Publication 20080020468A1 · Jan 24, 2008